However, between cancer cells and HLECs interaction, the PI3K/AKT in HLECs could be activated after the VEGF-C, from cancer cells, binds to its ligand VEGFR-3 on the surface of HLECs [15, 16]. This evidence concerns the gene FLT4 and cancer.